相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preparation and in vitro/in vivo evaluation of felodipine nanosuspension
Bhanu P. Sahu et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2014)
Formulation, optimization, and in vitro/in vivo evaluation of furosemide nanosuspension for enhancement of its oral bioavailability
Bhanu P. Sahu et al.
JOURNAL OF NANOPARTICLE RESEARCH (2014)
Paclitaxel nanosuspensions coated with P-gp inhibitory surfactants: I. Acute toxicity and pharmacokinetics studies
Lei Gao et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
In vivo anticancer and histopathology studies of Schiff bases on Ehrlich ascitic carcinoma cells
Dhanya Sunil et al.
ARABIAN JOURNAL OF CHEMISTRY (2013)
Human recombinant Cripto-1 increases doubling time and reduces proliferation of HeLa cells independent of pro-proliferation pathways
Asim Bikas Das et al.
CANCER LETTERS (2012)
Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice
Haiyan Lou et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2011)
Polyphenol contents and in vitro antioxidant activities of lyophilised aqueous extract of kiwifruit (Actinidia deliciosa)
Ercan Bursal et al.
FOOD RESEARCH INTERNATIONAL (2011)
Docetaxel-Loaded Pluronic P123 Polymeric Micelles: in Vitro and in Vivo Evaluation
Zhihong Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Preparation and antitumor study of camptothecin nanocrystals
Hua Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability
Dengning Xia et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Preparation, characterization, and biodistribution of letrozole loaded PLGA nanoparticles in Ehrlich Ascites tumor bearing mice
Nita Mondal et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Macromol. Biosci. 5/2010
Kamal K. Upadhyay et al.
MACROMOLECULAR BIOSCIENCE (2010)
Altered profiles of gene expression in curcumin-treated rats with experimentally induced myocardial infarction
Dongsheng Hong et al.
PHARMACOLOGICAL RESEARCH (2010)
Application of nanotechnology in cancer therapy and imaging
Xu Wang et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Antioxidant and radical scavenging properties of curcumin
Tuba Ak et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2008)
Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer
Tingyan Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Bioavailability of curcumin: Problems and promises
Preetha Anand et al.
MOLECULAR PHARMACEUTICS (2007)
Oral bioavailabilit of curcurnin in rat and the herbal analysis from Curcuma longa by LC-MS/MS
Kuo-Yi Yang et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester
Ben J. C. Quah et al.
NATURE PROTOCOLS (2007)
Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique
D. Douroumis et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2006)
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation
CM Keck et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2006)
Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting
TM Göppert et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs:: in vitro and in vivo evaluation
D Le Garrec et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Nanosuspensions: a promising drug delivery strategy
VB Patravale et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2004)
Molecular mechanisms of curcumin-induced cytotoxicity:: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt
JH Woo et al.
CARCINOGENESIS (2003)
P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel
Y Kimura et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Drug interaction studies between paclitaxel (Taxol) and OC144-093 - A new modulator of MDR in cancer chemotherapy
ES Guns et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2002)
Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: Production, colloidal properties and biological performance
S Stolnik et al.
JOURNAL OF DRUG TARGETING (2001)
分享论文
